Literature DB >> 1510787

Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development.

C O Jacob1, S Aiso, R D Schreiber, H O McDevitt.   

Abstract

In attempt to evaluate biological roles of tumor necrosis factor (TNF), we studied the effects of anti-TNF mAb in non-obese diabetic (NOD) mice. Anti-murine TNF mAb rendered NOD mice hypersensitive to the lethal effects of radiation and prevented the reconstitution of lethally irradiated mice with adoptively transferred lymphocytes. While TNF-alpha reduced the incidence of diabetes development in the adoptive transfer system even when given 6 days post-transfer, mAb to TNF could not reduce or increase the incidence of diabetes compared to control mice. Administration of TNF-alpha for 4 or 8 weeks significantly reduced the incidence of spontaneous insulitis in NOD mice, while anti-TNF mAb given for 8 weeks increased the incidence of insulitis significantly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510787     DOI: 10.1093/intimm/4.5.611

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

1.  Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55.

Authors:  R E Hunger; S Müller; J A Laissue; M W Hess; C Carnaud; I Garcia; C Mueller
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.

Authors:  A P Cope; R S Liblau; X D Yang; M Congia; C Laudanna; R D Schreiber; L Probert; G Kollias; H O McDevitt
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

Review 4.  Manipulating the type 1 vs type 2 balance in type 1 diabetes.

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 5.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 6.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 7.  Transgenic animal models for type 1 diabetes: linking a tetracycline-inducible promoter with a virus-inducible mouse model.

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

8.  Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection.

Authors:  D Artis; N E Humphreys; A J Bancroft; N J Rothwell; C S Potten; R K Grencis
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

9.  Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.

Authors:  I S Grewal; K D Grewal; F S Wong; D E Picarella; C A Janeway; R A Flavell
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.

Authors:  X D Yang; R Tisch; S M Singer; Z A Cao; R S Liblau; R D Schreiber; H O McDevitt
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.